PlexusDx's licensed 503A compounded versions maintain pharmaceutical-grade quality and sterility standards
In clinical trials, the most common observations were gastrointestinal effects: nausea (44.2% vs 17.4% placebo in STEP 1), diarrhea (30.0%), vomiting (24.8%), and constipation (24.2%)
Many studies have been carried out in animal models, which differ significantly in metabolism, gut microbiota composition, and immune system [133]
Low dose: Mild inflammation, early arthritis, preventive support
Start smaller If you are early in GLP-1 treatment, dose escalation, or a nausea-prone phase, a Venti drink may be too much
GSE51981 included 77 EMs samples and 34 normal controls (without other common uterine/pelvic pathologies)